VRTX
福泰 VERTEX PHARMACEUTICALS INC / MA
-0.35 (-0.07%)512.91USD239K成交股數130B市值29.9本益比(近四季)10.3股價營收比+12.4%營收年增(近四季)2026-11-02下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 4 · 2.3M · 4 |
| 其中 10b5-1 計畫賣出 | 4 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 12.5M |
| 近 180 天 淨額 | −12.5M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 09-10 | van Grunsven Jasper | EVP, CP and NPPO | A 獲配股票 | 8.7K | – | – | 8.7K | SEC |
| 2026-08-28 | 09-01 | Ambrose Kristen | SVP & Chief Accounting Officer | A 獲配股票 | 5.0K | – | – | 11.6K | SEC |
| 2026-08-27 | 08-31 | SACHS BRUCE I | Director | G 贈與 | 6.0K | – | – | 39.0K | SEC |
| 2026-07-21 | 07-23 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | A 獲配股票 | 8.3K | – | – | 53.6K | SEC |
| 2026-07-21 | 07-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | A 獲配股票 | 8.3K | – | – | 66.5K | SEC |
| 2026-07-02 | 07-07 | McKechnie Duncan | EVP, Chief Commercial Officer | S 公開市場賣出(10b5-1) | 1.5K | 519.00 | 800K | 11.0K | SEC |
| 2026-07-02 | 07-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S 公開市場賣出(10b5-1) | 1.5K | 524.99 | 787K | 45.3K | SEC |
| 2026-07-01 | 07-06 | Liu Joy | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 828 | 502.71 | 416K | 19.1K | SEC |
| 2026-06-26 | 06-30 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 596 | 482.50 | 288K | 15.3K | SEC |
| 2026-06-18 | 06-23 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 1.0K | 462.17 | 471K | 15.9K | SEC |
| 2026-06-15 | 06-17 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 4.1K | 450.00 | 1.8M | 17.0K | SEC |
| 2026-06-05 | 06-09 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 1.7K | 450.00 | 785K | 21.0K | SEC |
| 2026-06-01 | 06-03 | Liu Joy | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 828 | 439.91 | 364K | 20.0K | SEC |
| 2026-05-29 | 06-02 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 2.0K | 450.00 | 888K | 22.8K | SEC |
| 2026-05-15 | 05-19 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 1.4K | 453.45 | 614K | 24.7K | SEC |
| 2026-05-15 | 05-19 | Bunnage Mark E. | EVP, Chief Scientific Officer | S 公開市場賣出(10b5-1) | 33 | 453.45 | 15K | 7.3K | SEC |
| 2026-05-12 | 05-14 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 7.0K | 450.00 | 3.1M | 26.1K | SEC |
| 2026-05-04 | 05-05 | Bhatia Sangeeta N. | Director | S 公開市場賣出(10b5-1) | 318 | 423.73 | 135K | 4.9K | SEC |
| 2026-05-01 | 05-05 | Bhatia Sangeeta N. | Director | A 獲配股票 | 943 | – | – | 5.2K | SEC |
| 2026-05-01 | 05-05 | Schneider Jennifer | Director | A 獲配股票 | 472 | – | – | 2.2K | SEC |
| 2026-05-01 | 05-05 | Thornberry Nancy | Director | D 處分 | 398 | – | – | 2.1K | SEC |
| 2026-05-01 | 05-05 | Thornberry Nancy | Director | A 獲配股票 | 472 | – | – | 2.5K | SEC |
| 2026-05-01 | 05-05 | Schneider Jennifer | Director | D 處分 | 796 | – | – | 1.4K | SEC |
| 2026-05-01 | 05-05 | MCKENZIE DIANA | Director | A 獲配股票 | 943 | – | – | 3.2K | SEC |
| 2026-05-01 | 05-05 | Liu Joy | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 1.1K | 425.02 | 469K | 20.7K | SEC |
| 2026-05-01 | 05-05 | MCKENZIE DIANA | Director | D 處分 | 796 | – | – | 2.4K | SEC |
| 2026-05-01 | 05-05 | Garber Alan M | Director | A 獲配股票 | 472 | – | – | 7.3K | SEC |
| 2026-05-01 | 05-05 | Upadhyay Suketu | Director | D 處分 | 796 | – | – | 1.6K | SEC |
| 2026-04-01 | 04-03 | Liu Joy | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 978 | 449.17 | 439K | 21.8K | SEC |
| 2026-03-27 | 03-31 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 2.3K | 450.95 | 1.1M | 33.1K | SEC |
| 2026-03-13 | 03-17 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 2.3K | 481.79 | 1.1M | 35.4K | SEC |
| 2026-03-11 | 03-13 | McKechnie Duncan | EVP, Chief Commercial Officer | S 公開市場賣出(10b5-1) | 2.6K | 498.42 | 1.3M | 12.5K | SEC |
| 2026-03-04 | 03-06 | McKechnie Duncan | EVP, Chief Commercial Officer | S 公開市場賣出(10b5-1) | 2.4K | 475.30 | 1.2M | 15.1K | SEC |
| 2026-03-02 | 03-04 | Liu Joy | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 892 | 495.96 | 442K | 22.8K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 1.7K | 496.95 | 857K | 98.3K | SEC |
| 2026-02-27 | 03-03 | Bozic Carmen | EVP and CMO | S 公開市場賣出(10b5-1) | 2.3K | 480.31 | 1.1M | 37.7K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 15.6K | 495.38 | 7.7M | 106K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 3.5K | 494.33 | 1.7M | 122K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 2.5K | 493.29 | 1.2M | 125K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 949 | 491.30 | 466K | 128K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 2.7K | 490.54 | 1.3M | 129K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 460 | 489.32 | 225K | 131K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 3.3K | 488.27 | 1.6M | 132K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 240 | 482.84 | 116K | 138K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 2.5K | 487.13 | 1.2M | 135K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 6.0K | 496.16 | 3.0M | 100K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 120 | 481.50 | 58K | 138K | SEC |
| 2026-02-27 | 03-03 | Kewalramani Reshma | CEO & President | S 公開市場賣出(10b5-1) | 400 | 479.75 | 192K | 138K | SEC |
| 2026-02-26 | 03-02 | Ambrose Kristen | SVP & Chief Accounting Officer | S 公開市場賣出(10b5-1) | 357 | 483.36 | 173K | 6.6K | SEC |
| 2026-02-25 | 02-26 | McKechnie Duncan | EVP, Chief Commercial Officer | S 公開市場賣出(10b5-1) | 2.5K | 486.35 | 1.2M | 20.0K | SEC |
| 2026-02-25 | 02-26 | Bunnage Mark E. | EVP, Chief Scientific Officer | S 公開市場賣出(10b5-1) | 620 | 486.35 | 302K | 7.3K | SEC |
| 2026-02-25 | 02-26 | McKechnie Duncan | EVP, Chief Commercial Officer | S 公開市場賣出(10b5-1) | 2.4K | 489.00 | 1.2M | 17.6K | SEC |
| 2026-02-25 | 02-26 | Biller Jonathan | EVP and Chief Legal Officer | S 公開市場賣出(10b5-1) | 945 | 486.35 | 460K | 13.7K | SEC |
| 2026-02-25 | 02-26 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S 公開市場賣出(10b5-1) | 668 | 486.35 | 325K | 18.4K | SEC |
| 2026-02-25 | 02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | S 公開市場賣出(10b5-1) | 223 | 486.35 | 108K | 7.0K | SEC |
| 2026-02-25 | 02-26 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 1.8K | 486.35 | 898K | 55.6K | SEC |
| 2026-02-25 | 02-26 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | S 公開市場賣出(10b5-1) | 260 | 486.35 | 126K | 46.8K | SEC |
| 2026-02-24 | 02-26 | Sachdev Amit | EVP Chief Patient & Ext Af Off | F 繳稅扣股 | 1.5K | 485.11 | 736K | 57.4K | SEC |
| 2026-02-24 | 02-26 | McKechnie Duncan | EVP, Chief Commercial Officer | F 繳稅扣股 | 873 | 485.11 | 424K | 22.5K | SEC |
| 2026-02-24 | 02-26 | Kewalramani Reshma | CEO & President | F 繳稅扣股 | 5.0K | 485.11 | 2.4M | 138K | SEC |
| 2026-02-24 | 02-26 | Bunnage Mark E. | EVP, Chief Scientific Officer | F 繳稅扣股 | 582 | 485.11 | 282K | 7.9K | SEC |
| 2026-02-24 | 02-26 | Bozic Carmen | EVP and CMO | F 繳稅扣股 | 1.5K | 485.11 | 705K | 40.1K | SEC |
| 2026-02-24 | 02-26 | Biller Jonathan | EVP and Chief Legal Officer | F 繳稅扣股 | 1.1K | 485.11 | 555K | 14.6K | SEC |
| 2026-02-24 | 02-26 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | F 繳稅扣股 | 1.6K | 485.11 | 789K | 19.1K | SEC |
| 2026-02-24 | 02-26 | LEIDEN JEFFREY M | Executive Chairman | F 繳稅扣股 | 3.5K | 485.11 | 1.7M | 34.8K | SEC |
| 2026-02-24 | 02-26 | WAGNER CHARLES F JR | EVP, CO & FO | F 繳稅扣股 | 1.7K | 485.11 | 846K | 47.0K | SEC |
| 2026-02-24 | 02-26 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | F 繳稅扣股 | 1.6K | 485.11 | 789K | 47.0K | SEC |
| 2026-02-24 | 02-26 | Ambrose Kristen | SVP & Chief Accounting Officer | F 繳稅扣股 | 546 | 485.11 | 265K | 7.2K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | M 選擇權執行 | 23.5K | 155.57 | 3.7M | 92.5K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 7.2K | 469.61 | 3.4M | 74.9K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 11.7K | 470.54 | 5.5M | 63.2K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 2.7K | 465.05 | 1.3M | 114K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 19.7K | 468.57 | 9.2M | 82.1K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 10.3K | 467.75 | 4.8M | 102K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 1.8K | 465.80 | 861K | 112K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 920 | 463.91 | 427K | 117K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | M 選擇權執行 | 25.0K | 187.53 | 4.7M | 118K | SEC |
| 2026-02-19 | 02-23 | Sachdev Amit | EVP Chief Patient & Ext Af Off | S 公開市場賣出(10b5-1) | 4.2K | 471.43 | 2.0M | 58.9K | SEC |
| 2026-02-18 | 02-19 | Ambrose Kristen | SVP & Chief Accounting Officer | S 公開市場賣出(10b5-1) | 638 | 473.68 | 302K | 7.8K | SEC |
| 2026-02-18 | 02-19 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | S 公開市場賣出(10b5-1) | 817 | 473.68 | 387K | 20.7K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Capital World Investors | 26.1M | 13.0B | +747K (+3%) | 加碼 |
| BlackRock, Inc. | 24.1M | 12.0B | +140K (+1%) | 加碼 |
| Capital Research Global Investors | 19.5M | 9.7B | −1.6M (-8%) | 減碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 16.6M | 8.2B | +67.9K (+0%) | 加碼 |
| STATE STREET CORP | 11.9M | 5.9B | +141K (+1%) | 加碼 |
| Invesco Ltd. | 8.0M | 4.0B | +150K (+2%) | 加碼 |
| JPMORGAN CHASE & CO | 6.5M | 3.3B | −516K (-7%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 6.0M | 3.0B | −122K (-2%) | 減碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9M | 2.4B | −267K (-5%) | 減碼 |
| Capital International Investors | 4.7M | 2.3B | −431K (-8%) | 減碼 |
| LOOMIS SAYLES & CO L P | 3.9M | 1.9B | −82.9K (-2%) | 減碼 |
| FRANKLIN RESOURCES INC | 3.3M | 1.7B | +2.8M (+507%) | 加碼 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.2M | 1.6B | +35.1K (+1%) | 加碼 |
| MORGAN STANLEY | 3.2M | 1.6B | +53.3K (+2%) | 加碼 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3.1M | 1.5B | +29.3K (+1%) | 加碼 |
| BANK OF AMERICA CORP /DE/ | 3.0M | 1.5B | +161K (+6%) | 加碼 |
| JENNISON ASSOCIATES LLC | 3.0M | 1.5B | +258K (+9%) | 加碼 |
| 挪威主權基金 NORGES BANK | 3.0M | 1.5B | 新進 | 新進 |
| ALLIANCEBERNSTEIN L.P. | 3.0M | 1.3B | −891K (-23%) | 減碼 |
| AMERIPRISE FINANCIAL INC | 2.6M | 1.3B | −28.7K (-1%) | 減碼 |
| NORTHERN TRUST CORP | 2.5M | 1.2B | −77.8K (-3%) | 減碼 |
| GOLDMAN SACHS GROUP INC | 2.5M | 1.2B | +63.9K (+3%) | 加碼 |
| Clearbridge Investments, LLC | 2.3M | 1.2B | −358K (-13%) | 減碼 |
| VICTORY CAPITAL MANAGEMENT INC | 2.2M | 1.1B | +285K (+15%) | 加碼 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.0M | 1.0B | +120K (+6%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 1,756 +58 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 193 / 135 / 645 / 543 |
| 機構合計持股 · 佔流通股 | 242M · 95.6% |
| 合計季末市值 | 117B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 4.7M |
|---|---|
| 與上期比 | +12.4% |
| 佔流通股數 | 1.84% |
| 日均成交量 | 1.0M |
| 回補天數 | 4.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 4.7M | +12.4% | 1.84% | 1.0M | 4.5 |
| 2026-08-14 | 4.1M | +5.2% | 1.64% | 1.3M | 3.1 |
| 2026-07-31 | 3.9M | -20.9% | 1.56% | 1.3M | 3.0 |
| 2026-07-15 | 5.0M | +1.0% | 1.97% | 1.6M | 3.1 |
| 2026-06-30 | 4.9M | +7.0% | 1.95% | 2.5M | 2.0 |
| 2026-06-15 | 4.6M | +2.8% | 1.82% | 1.2M | 3.8 |
| 2026-05-29 | 4.5M | +0.7% | 1.77% | 1.4M | 3.2 |
| 2026-05-15 | 4.5M | +6.9% | 1.76% | 1.2M | 3.6 |
| 2026-04-30 | 4.2M | -3.8% | 1.65% | 968K | 4.3 |
| 2026-04-15 | 4.3M | +7.8% | 1.71% | 1.1M | 3.8 |
| 2026-03-31 | 4.0M | -2.6% | 1.59% | 1.5M | 2.7 |
| 2026-03-13 | 4.1M | -6.9% | 1.63% | 1.4M | 2.9 |
| 2026-02-27 | 4.4M | -0.7% | 1.75% | 1.3M | 3.5 |
| 2026-02-13 | 4.5M | +1.0% | 1.76% | 1.7M | 2.7 |
| 2026-01-30 | 4.4M | -0.0% | 1.74% | 1.6M | 2.8 |
| 2026-01-15 | 4.4M | -11.9% | 1.75% | 1.4M | 3.1 |
| 2025-12-31 | 5.0M | +17.1% | 1.98% | 1.2M | 4.1 |
| 2025-12-15 | 4.3M | -3.8% | 1.69% | 1.4M | 3.2 |
| 2025-11-28 | 4.5M | +11.2% | 1.76% | 1.4M | 3.2 |
| 2025-11-14 | 4.0M | -3.0% | 1.58% | 1.5M | 2.7 |
| 2025-10-31 | 4.1M | +16.2% | 1.63% | 1.3M | 3.2 |
| 2025-10-15 | 3.6M | -0.0% | 1.40% | 1.3M | 2.7 |
| 2025-09-30 | 3.6M | -12.3% | 1.40% | 2.0M | 1.8 |
| 2025-09-15 | 4.1M | +11.4% | 1.60% | 1.3M | 3.2 |
| 2025-08-29 | 3.6M | -1.7% | 1.44% | 1.6M | 2.3 |
| 2025-08-15 | 3.7M | -15.2% | 1.46% | 3.3M | 1.1 |